+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparative effects of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis



Comparative effects of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis and primary sclerosing cholangitis



Clinical Research 37(2): 365A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030618858

Download citation: RISBibTeXText


Related references

Effects of ursodiol on bile acid metabolism in primary biliary cirrhosis pbc and primary sclerosing cholangitis psc. Williams, C N (Ed ) Falk Symposium, 56 Trends in Inflammatory Bowel Disease Therapy; Symposium, Halifax, Nova Scotia, Canada, June 6-9, 1990 Xviii+462p Kluwer Academic Publishers: Dordrecht, Netherlands; (Dist in The Usa And Canada By Kluwer Academic Publishers: Hingham, Massachusetts, Usa) Illus 423, 1991

Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid. Current Gastroenterology Reports 1(1): 38-41, 2000

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis and primary sclerosing cholangitis in pregnancy. Hepatology 36(4 Part 2): 491A, 2002

The effect of ursodeoxycholic acid urso in primary sclerosing cholangitis a comparison to primary biliary cirrhosis. Gastroenterology 94(5 Part 2): A595, 1988

Urinary excretion of ursodeoxycholic acid during treatment of patients with primary biliary cirrhosis and primary sclerosing cholangitis. Journal of Hepatology 7, 1988

Ursodeoxycholic acid and biliary bile acid composition in primary sclerosing cholangitis Effect of Apo E phenotype. Gastroenterology 123(1 Suppl.): 65, 2002

Treatment of the primary biliary cirrhosis and sclerosing cholangitis with ursodeoxycholic acid. Journal of Hepatology 25(Suppl. 1): 210, 1996

Ursodeoxycholic acid therapy plays an immunomodulatory and anti-apoptotic role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Journal of Hepatology 38(Suppl. 2): 208, 2003

Single dose or multiple doses of ursodeoxycholic acid are equally effective in the treatment of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 108(4 Suppl. ): A1191, 1995

Ursodeoxycholic acid therapy affects the cytokine network and plays an immunomodulatory role in patients with primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 36(4 Part 2): 499A, 2002

Effect of ursodeoxycholic acid udca treatment on the biliary secretion of bile acids and bile lipids in primary sclerosing cholangitis psc. Gastroenterology 98(5 Part 2): A637, 1990

Effects of ursodeoxycholic acid udca on liver function tests and bile acid metabolism in anicteric primary biliary cirrhosis pbc a dose response study. Hepatology 8(5): 1266, 1988

Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. Journal of Hepatology 23(3): 283-289, 1995

Biliary bile acid composition in untreated primary biliary cirrhosis and sclerosing cholangitis neither disease specific nor of prognostic value. Hepatology 14(4 Part 2): 259A, 1991

Effect of ursodeoxycholic acid on biliary lipid secretion and bile acid metabolism in primary biliary cirrhosis. Hepatology 8(5): 1317, 1988